Abstract
Although drugs are used primarily for the treatment of disease, surprisingly little is known of the way in which disease states or physiological factors modify drug action in man. In contrast, extensive studies in laboratory animals have shown that these factors can have striking effects which if applied to man would have enormous clinical significance. The failure to apply this basic knowledge to clinical medicine amounts virtually to negligence on the part of the medical profession.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adjepon-Yamoah, K.K., Scott, D.B., Prescott, L.F.: Impaired absorption and metabolism of oral lidocaine in patients undergoing laparoseopy. Brit. J. Anesth. 45, 143–147 (1973).
Andersson, S.: Variation in gastrointestinal functions influencing the absorption of drugs. Acta Pharmacol. (Kbh.) 29, Suppl. 3, 103–108 (1971).
Anton, A.H., Corey, W.T.: Interindividual differences in the protein binding of sulfonamides: the effect of disease and drugs. Acta pharmacol. (Kbh.) 29, Suppl. 3, 134–151 (1971).
Armstrong, B.K., Ukich, A.W., Goatcher, P.M.: Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations. Med. J. Aust. 2, 181–182 (1970).
Balasubramaniam, K., Mawer, G.E., Pohl, J.E.F., Simons, P. J.G.: Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency. Brit. J. Pharmacol. 45, 360–367 (1972).
Balasubramaniam, K., Mawer, G.E., Simons, P. J.: The influence of dose on the distribution and elimination of amylobarbitone in healthy subjects. Brit. J. Pharmacol. 40, 578–579 P. (1970).
Ballinger, B., Browning, M., O’Malley, K., Stevenson, I.H.: Drug-metabolizing capacity in states of drug dependence and withdrawal. Brit. J. Pharmacol. 45, 638–643 (1972).
Baraka, A., Gabali, F.: Correlation between tubocurarine requirements and plasma protein pattern. Brit. J. Anaesth. 40, 89–93 (1968).
Beermann, B., Hellström, K., Rosen, A.: On the metabolism of propantheline in man. Clin. Pharmacol. Ther. 13, 212–220 (1972).
Bellet, S., Roman, L.R., Boza, A.: Relation between serum quinidine levels and renal function. Amer. J. Cardiol. 27, 368–371 (1971).
Beresford, C.H., Neale, R.J., Brooks, O.G.: Iron absorption and pyrexia. Lancet 1971 I, 568–572.
Bianchine, J.R., Callmlim, L.R., Morgan, J.P., Dujuvne, C.A., Lasagna, L.: Metabolism and absorption of L-3, 4-dihydroxyphenylalanine in patients with Parkinson’s disease. Ann. N. Y. Acad. Sci. 179, 126–140 (1971).
Bigland, B., Goetzee, B., MacLagan, J., Zaimis, E.: The effect of lowered muscle temperature on the action of neuromuscular blocking agents. J. Physiol. (Lond.) 141, 425–434 (1958).
Bluemle, L.W., Goldberg, M. J.: Renal accumulation of salicylate and phenacetin; possible mechanisms in the nephrotoxicity of analgesic abuse. J. clin. Invest. 47, 2507–2514 (1968).
Bogoch, A., Davis, T.W., Jow, E., Wrenshall, G.A.: The clinical response and amount of insulin extractable from the pancreas in diabetic patients treated with oral hypoglycemic drugs. Canad. med. Ass. J. 81, 347–356 (1959).
Brodie, B.B.: Physicochemical factors in drug absorption. In: Binns, T.B. (Ed.): Absorption and distribution of drugs, pp. 16–48. Baltimore: Williams and Wilkins 1964.
Chignell, C.F., Vesell, E.S., Starkweather, D.K., Berlin, C.M.: The binding of sulfa-phenazole to fetal, neonatal, and adult human plasma albumin. Clin. Pharmacol. Ther. 12, 897–901 (1971).
Clarke, R.A., Julian, D.G., Nimmo, J., Prescott, L.F., Talbot, R.: Clinical pharmacological studies of Kö 1173—a new antiarrhythmic agent. Brit. J. Pharmacol. Abstr. 47, 622–623 P. (1973).
Conney, A.H., Welch, R., Kuntzman, R., Chang, R., Jacobson, M., Munrofaure, A.D., Peck, A.W., Bye, A., Poland, A., Poppers, P.J., Finster, M., Wolff, J.A.: Effects of environmental chemicals on the metabolism of drugs, carcinogens, and normal body constituents in man. Ann. N. Y. Acad. Sci. 179, 155–172 (1971).
Covino, B.G.: Local anesthesia. New Engl. J. Med. 286, 1035–1042 (1972).
Creaven, P.J., Allen, L.M.: Renal clearance of camptothecin sodium in man; effect of urine volume. Fifth International Congress on Pharmacology, San Francisco, Abstr. No. 283, p. 48 (1972).
Crounse, R.G.: Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption. J. invest. Derm. 37, 529–533 (1961).
Curtis, J.R., Marshall, M.J.: Cephaloridine serum levels in patients on maintenance hemodialysis. Brit. med. J. 1970 II, 149–151.
Cutler, R.E., Orme, B.M.: Correlation of serum creatinine concentration and kanamycin half-life: Therapeutic implications. J. Amer. med. Ass. 209, 539–542 (1969).
Das, K.M., Eastwood, M.A.: Personal communication.
Davis, A. E., Pirola, R.C.: Absorption of phenoxymethyl penicillin in patients with steatorrhea. Aust. Ann. Med. 17, 63–65 (1968).
Dettli, L., Spring, P., Habersang, R.: Drug dosage in patients with impaired renal function. Postgrad, med. J. 46, Suppl., 32–35 (1970).
DoLuisio, J.T., Tan, G.H., Billups, N.F., Diamond, L.: Drug absorption. II. Effect of fasting on intestinal drug absorption. J. pharm. Sci. 58, 1200–1202 (1969).
Dreifus, L.S., Duarte, C., Kodama, R., Moyer, J.H.: The effect of thiazide diuretics on the abnormal kidney. Ann. intern. Med. 53, 1170–1179 (1960).
Dundee, J. W.: Thiopentone and other thiobarbiturates, p. 137. Edinburgh: Livingstone 1956.
Dundee, J. W., Richards, R.K.: The effect of azotemia upon the action of intravenous barbiturate anesthesia. Anesthesiology 15, 333–346 (1954).
Ebadi, M.S., Kugel, R.B.: Alteration in metabolism of acetylsalicylic acid in children with Down’s syndrome: Decreased plasma binding and formation of salicyluric acid. Pediat. Res. 4, 187–193 (1970).
Fischer, E.: Renal excretion of sulfadimidine in normal and uraemic subjects. Lancet 1972II, 210–212.
Gilbertson, A.A., Boulton, T.B.: Anesthesia in difficult situations. The influence of disease on pre-operative preparation and choice of anesthetic. Anesthesia 22, 607–630 (1967).
Gillette, J.R.: Factors affecting drug metabolism. Ann. N.Y. Acad. Sci. 179, 43–66 (1971).
Gladtke, E.: Beeinflussung der Arzneimitteltherapie durch pathologische Zustände. J. mond. Pharm. (La Haye) 14, 230–250 (1971).
Gower, P.E., Dash, C.H.: Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic. Brit. J. Pharmacol. 37, 738–747 (1969).
Gwilt, J.R., Robertson, A., Goldman, L., Blanchard, A.W.: The absorption characteristics of paracetamol tablets in man. J. Pharm. Pharmacol. 15, 445–453 (1963).
Haass, A., Lullmann, H., Peters, T.: Absorption rates of some cardiac glycosides and portal blood flow. Europ. J. Pharmacol. 19, 366–370 (1972).
Hammar, C.-H., Prellwitz, W.: Die Glucuronidbildung nach peroraler Belastung mit Acet-anilid bei chronischer Hepatitis und Lebercirrhose. Klin. Wschr. 44, 1010–1014 (1966).
Harrison, T.S.: Adrenal medullary and thyroid relationships. Physiol. Rev. 44, 161–185 (1964).
Hartiala, K., Kasanen, A., Raussi, M.: The absorption of salicylamide in pernicious anemia, gastric achylia, and peptic ulcer. Ann. Med. exp. Fenn. 41, 549–553 (1963).
Hayes, A.H.: Intravenous infusion of lidocaine in the control of ventricular arrhythmias. In: Scott, D.B., Julian, D.G. (Eds.): Lidocaine in the treatment of ventricular arrhythmias, pp. 189–199. Edinburgh: Livingstone 1971.
Heading, R.C., Nlmmo, J., Prescott, L.F., Tothill, P.: The dependence of paracetamol absorption on the rate of gastric emptying. Brit. J. Pharmacol. 47, 415–421 (1973).
Heizer, W.D., Smith, T. W., Goldfinger, S.E.: Absorption of digoxin in patients with malabsorption syndromes. New Engl. J. Med. 285, 257–259 (1971).
Held, H., Oldershausen, H.F.: Zur Pharmakokinetik von Meprobamat bei chronischen Hepatopathien und Arzneimittelsucht. Klin. Wschr. 47, 78–80 (1969).
Held, H., Oldershausen, H.F.: Drug metabolism in acute and chronic liver disease. Digestion 4, 151 (Abstr.) (1971).
Howell, A., Sutherland, R., Robinson, G.N.: Effect of protein binding on levels of ampi-cillin and cloxacillin in synovial fluid. Clin. Pharmacol. Ther. 13, 724–732 (1972).
Jafpe, J.M., Colaizzi, J.L., Barry, H.: Effects of dietary components on GI absorption of acetaminophen tablets in man. J. pharm. Sci. 60, 1646–1650 (1971).
Jollow, D.J., Mitchell, J.R., Potter, W.Z., Davis, D.C., Gillette, J.R., Brodie, B.B.: Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. exp. Ther. 187, 195–202 (1973).
Kater, R.M.H., Roggin, G., Tobon, F., Zieve, P., Iber, F.L.: Increased rate of clearance of drugs from the circulation of alcoholics. Amer. J. med. Sci. 258, 35–39 (1969).
Kekki, M., Pyörälä, K., Mustala, O., Salmi, H., Jussila, J., Siurala, M.: Multicompartment analysis of the absorption kinetics of warfarin from the stomach and small intestine. Int. J. clin. Pharmacol. 5, 209–211 (1971).
King, J. O., Denborough, M.A., Zapf, P. W.: Inheritance of malignant hyperpyrexia. Lancet 1972I, 365–370.
Koch-Weser, J.: Pharmacokinetics of procainamide in man. Ann. N.Y. Acad. Sci. 179, 370–382 (1971).
Koch-Weser, J., Klein, S.W.: Procainamide dosage schedules, plasma concentrations and clinical effects. J. Amer. med. Ass. 215, 1454–1460 (1971).
Kojima, S., Smith, R.B., Doluisio, J.T.: Drug absorption. V. Influence of food on oral absorption of phenobarbital in rats. J. pharm. Sci. 60, 1639–1641 (1971).
Kuntzman, R.G., Tsai, I., Brand, L., Mark, L.C.: The influence of urinary pH on the plasma half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma. Clin. Pharmacol. Ther. 12, 62–67 (1971).
Kutt, H., Winters, W., Scherman, R., McDowell, F.: Diphenylhydantoin and phenobarbital toxicity. Arch. Neurol. (Chic.) 11, 649–656 (1964).
Laidlaw, J., Read, A. E., Sherlock, S.: Morphine tolerance in hepatic cirrhosis. Gastroenterology 40, 389–396 (1961).
Letteri, J.M., Mellk, H., Louis, S., Kutt, H., Durante, P., Glazko, A.: Diphenylhydantoin metabolism in uremia. New. Engl. J. Med. 285, 648–652 (1971).
Levi, A. J., Sherlock, S., Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1968I, 1275–1279.
Levine, R.R.: Factors affecting gastrointestinal absorption of drugs. Digest. Dis. 15, 171–188 (1970).
Levy, G., Gibaldi, M., Procknal, J.A.: Effect of an anticholinergic agent on riboflavin absorption in man. J. pharm. Sci. 61, 798–799 (1972).
Lewis, G. P., Jusko, W.J., Burke, C.W., Graves, L.: Prednisone side-effects and serum-protein levels. Lancet 1971II, 778–780.
Luchi, R.J., Gruber, J.W.: Unusually large digitalis requirements: a study of altered digoxin metabolism. Amer. J. Med. 45, 322–328 (1968).
Lund, L., Berlin, A., Lunde, P.K.M.: Plasma protein binding of diphenylhydantoin in patients with epilepsy. Clin. Pharmacol. Ther. 13, 196–200 (1972).
MacDonald, H., Place, V.A., Falk, H., Darken, M.A.: Effect of food on absorption of sulfonamides in man. Chemotherapia (Basel) 12, 282–285 (1967).
Mason, D.T., Braunwald, E.: Symposium on congestive heart failure. II. Digitalis: new facts about an old drug. Amer. J. Cardiol. 22, 151–161 (1968).
Mattila, M.J., Friman, A., Larmi, T.K.L, Koskinen, R.: Absorption of ethionamid, iso-niazid, and aminosalicylic acid from the post-resection gastrointestinal tract. Ann. Med. exp. Fenn. 47, 209–212 (1969).
Mawer, G.E., Miller, N.E., Turnberg, L.A.: Metabolism of amylobarbitone in patients with chronic liver disease. Brit. J. Pharmacol. 44, 549–560 (1972).
Mcgilveray, I.J., Mattok, G.L.: Some factors affecting the absorption of paracetamol. J. Pharm. Pharmacol. 24, 615–619 (1972).
McHenry, M.C., Gavan, T.L., Gifford, R.W., Jr., Geurkink, N.A., van Ommen, R.A., Town, M.A., Wagner, J.G.: Gentamicin dosages for renal insufficiency: Adjustments based on endogenous creatinine clearance and serum creatinine concentration. Ann. intern. Med. 74, 192–197 (1971).
Menguy, R., Desbaillets, L., Okabe, S., Masters, Y.F.: Abnormal aspirin metabolism in patients with cirrhosis and its possible relationship to bleeding in cirrhotics. Ann. Surg. 176, 412–418 (1972).
Meyer, M.B., Zelechowski, K.: Intramuscular lidocaine in normal subjects. In: Scott, D.B., Julian, D.G. (Eds.): Lidocaine in the treatment of ventricular arrhythmias, pp. 161–168. Edinburgh: Livingstone 1971.
Mitchell, J.R., Jollow, D.J., Potter, W.Z., Davis, D.C., Gillette, J.R., Brodie, B.B.: Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol, exp. Ther. 187, 185–194 (1973).
Murray-Lyon, I.M., Young, J., Parkes, J. D., Kntll-Jones, R.P., Williams, R.: Clinical and electroencephalographs assessment of diazepam in liver disease. Brit. med. J. 4, 265–266 (1971).
Myhre, E., Brodwall, E.K., Stenbaek, O., Hansen, T.: Plasma turnover of methyldopa in advanced renal failure. Acta med. scand. 191, 343–347 (1972).
Nanra, R.S., Hicks, J.D., McNamara, J.H., Lie, J.T., Leslie, D.W., Jackson, B., Kincaid-Smith, P.: Seasonal variation in the post-mortem incidence of renal papillary necrosis. Med. J. Aust. 1, 293–296 (1970).
Nelson, E.: Rate of metabolism of tolbutamide in test subjects with liver disease or with impaired renal function. Amer. J. med. Sci. 248, 657–659 (1964).
Nelson, J. D., Shelton, S., Kusmiesz, H.T., Haltalin, K.C.: Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clin. Pharmacol. Ther. 13, 879–886 (1972).
Nimmo, J., Heading, R.C., Tothill, P., Prescott, L.F.: Pharmacological modification of gastric emptying: effects of propantheline and metoclopramide on paracetamol absorption. Brit. med. J. 1, 587–589 (1973).
Odar-Cederlöf, L., Lunde, P., Sjöqvist, F.: Abnormal pharmacokinetics of phenytoin in a patient with uremia. Lancet 1970II, 831–832.
Ohnhaus, E.E.: The pharmacokinetics of unchanged pindolol in patients with impaired renal function. Brit. J. Pharmacol. Abstr. 47, 620–621 P. (1973).
O’Malley, K., Crooks, J., Duke, E., Stevenson, I.H.: Effect of age and sex on human drug metabolism. Brit. med. J. 1971 III, 607–609.
Peterson, O.L., Finland, M.: The effect of food and alkali on the absorption and excretion of sulfonamide drugs after oral and duodenal administration. Amer. J. med. Sci. 204, 581–588 (1942).
Place, V.A., Benson, H.: Dietary influences on therapy with drugs. J. mond. Pharm. 14, 261–278 (1971).
Potter, W.Z., Davis, D.C., Mitchell, J. R., Jollow, D.J., Gillette, J. R., Brodle, B.B.: Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. exp. Ther. 187, 203–210 (1973).
Prescott, L.F.: Mechanisms of renal excretion of drugs (with special reference to drugs used by anesthetists). Brit. J. Anesth. 44, 246–251 (1972).
Prescott, L.F., Nimmo, J.: Generic inequivalence—clinical observations. Acta pharmacol. (Kbh.) 29, Suppl. 3, 288–303 (1971a).
Prescott, L.F., Nimmo, J.: Drug therapy—physiological considerations. J. mond. Pharm. (La Haye) 14, 253–260 (1971b).
Prescott, L.F., Nimmo, J.: Plasma lidocaine concentrations during and after prolonged infusions in patients with myocardial infarction. In: Scott, D.B., Julian, D.G. (Eds.): Lidocaine in the treatment of ventricular arrhythmias, pp. 168–177. Edinburgh: Livingstone 1971c.
Prescott, L. F., Roscoe, P., Forrest, J. A. H.: Plasma concentrations and drug toxicity. II. Toxicity in man. In: Davies, D.S., Pritchard, B. N. C. (Eds): Biological effects of drugs in relation to their plasma concentrations, pp. 51–81. London: Macmillan 1973.
Prescott, L. F., Roscoe, P., Wright, N., Brown, S.S.: Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971I, 519–522.
Prescott, L.F., Steel, R.F., Ferrier, W.R.: The effects of particle size on the absorption of phenacetin in man. Clin. Pharmacol. Ther. 11, 496–504 (1970).
Prescott, L.F., Stevenson, I.H.: Liver disease and drug metabolism in man. In: Proceedings of the Fifth International Congress on Pharmacology. Basel: Karger 3, 182–190, 1973.
Price-Evans, D.A.: Inter-individual differences in the metabolism of drugs: the role of genetic factors. Acta pharmacol. (KM.) 29, Suppl. 3, 156–163 (1971).
Reidenberg, M.M.: Renal function and drug action, pp. 1–3, 33–37. Philadelphia: Saunders 1971.
Reidenberg, M.M.: Effect of kidney disease on pharmacokinetics and drug response. In: Proceedings of the Fifth International Congress on Pharmacology. Basel: Karger 1973.
Reidenberg, M.M., James, M., Dring, L.G.: The rate of procaine hydrolysis in serum of normal subjects and diseased patients. Clin. Pharmacol. Ther. 13, 279–284 (1972).
Reidenberg, M.M., Odar-Cederlöf, I., von Bahr, C., Borga, O., Sjöqvest, F.: Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl. J. Med. 285, 264–267 (1971).
Ristola, P., Pyörälä, K.: Determinants of the response to coumarin anticoagulants in patients with acute myocardial infarction. Acta med. scand. 192, 183–188 (1972).
Ryan, J.F., Kagen, L.J., Hyman, A.I.: Myoglobinemia after a single dose of succinyl-choline. New Engl. J. Med. 285, 824–827 (1971).
Sales, J.E.L., Sutclipfe, M., O’Grady, F.: Cephalexin levels in human bile in presence of biliary tract disease. Brit. med. J.1972 III, 441–443.
Schedl, H.P., Clifton, J.A.: Cortisol absorption in man. Gastroenterology 44, 134–145 (1963).
Scheiner, J., Altemeier, W.A.: Experimental study of factors inhibiting absorption and effective therapeutic levels of declomycin. Surg. Gyn. Obstet. 114, 9–14 (1962).
Schoene, B., Fleischmann, R. A., Remmer, H.: Determination of drug metabolizing enzymes in needle biopsies of human liver. Europ. J. clin. Pharmacol. 4, 65–73 (1972).
Schreiner, G.E.: Dialysis of poisons and drugs—Annual review. Trans. Amer. Soc. Artif. Int. Organs 16, 544–568 (1970).
Schröder, H., Campbell, D.E.S.: Absorption, metabolism, and excretion of salicylazosulfa-pyridine in man. Clin. Pharmacol. Ther. 13, 539–551 (1972).
Sereni, F., Perletti, L., Marubini, E., Mars, G.: Pharmacokinetic studies with a long-acting sulfonamide in subjects of different ages. Pediat. Res. 2, 29–37 (1968).
Sessions, J.T., Minkel, H.P., Bullard, J.C., Ingelfinger, F.J.: The effect of barbiturates in patients with liver disease. J. clin. Invest. 33, 1116–1127 (1954).
Shideman, F.E., Kelly, A.R., Lee, L.E., Lowell, V.F., Adams, B.J.: The role of the liver in the detoxification of thiopental (pentothal) by man. Anesthesiology 10, 421–427 (1949).
Siegers, C.-P., Strubelt, O., Back, G.: Inhibition by caffeine of ethanol absorption in rats. Europ. J. Pharmacol. 20, 181–187 (1972).
Siurala, M., Mttstala, O., Jtjssila, J.: Absorption of acetylsalicylic acid by a normal and atrophic gastric mucosa. Scand. J. Gastroent. 4, 269–273 (1969).
Sotaniemi, E., Huhti, E., Arvela, P., Koivisto, O.: Tolbutamide clearance from the blood in hypercapnia. Scand. J. clin. Lab. Invest. 27, Suppl. 78 (Abstr.) (1971).
Smith, R.B., Petruscak, J.: Succinylcholine, digitalis, and hypercalcemia: a case report. Anesth. Anaig. Curr. Res. 51, 202–205 (1972).
Stenbaek, Ø., Myhre, E., Brodwall, E.K., Hansen, T.: Hypotensive effect of methyldopa in renal failure associated with hypertension. Acta med. scand. 191, 333–337 (1972).
Thompson, F.D., Joekes, A.M., Foulkes, D.M.: Pharmacodynamics of propranolol in renal failure. Brit. med. J. 1972II, 434–436.
Thomson, P.D., Rowland, M., Melmon, K.L.: The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Amer. Heart J. 82, 417–421 (1971).
Tobey, R.E., Jacobsen, P.M., Kahle, C.T., Clubb, R.J., Dean, M.A.: The serum potassium response to muscle relaxants in neural injury. Anesthesiology 37, 332–337 (1972).
Tolomie, J.D., Joyce, T.H., Mitchell, G.D.: Succinylcholine danger in the burned patient. Anesthesiology 28, 467–470 (1967).
Ueda, H., Sakurai, T., Ota, M., Nakajima, A., Kamii, K., Maezawa, H.: Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis, and renal disease, Diabetes 12, 414–419 (1963).
Vagenakis, A.G., Cote, R., Miller, M.E., Braverman, L.E., Stohlman, F., Jr.: Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis. Johns Hopk. med. J. 131, 69–75 (1972).
Venho, V.M.K., Jussila, J., Aukee, S.: Drug absorption in man after gastric suergry. Fifth International Congress on Pharmacology, San Francisco. Abstract No. 1445, 241 (1972).
Waddell, W.J., Butler, T.C.: The distribution and excretion of phénobarbital. J. clin. Invest. 36, 1217–1226 (1957).
Webb, D.I., Chodos, R.B., Mahar, C.Q., Faloon, W.W.: Mechanism of vitamin B12 malabsorption in patients receiving colchicine. New Engl. J. Med. 279, 845–850 (1968).
Wechselberg, K.: Salizylsäure-Vergiftung durch perkutane Resorption l%iger Salizyl-vaseline. Pädiat. Prax. 7, 431–433 (1968).
Whelton, A., Sapir, D.G., Carter, G.G., Kramer, J., Walker, W.G.: Intrarenal distribution of penicillin, cephalothin, ampicillin, and Oxytetracycline during varied states of hydration. J. Pharmacol, exp. Ther. 179, 419–428 (1971).
White, R.J., Chamberlain, D.A., Howard, M., Smith, T.W.: Plasma concentrations of digoxin after oral administration in the fasting and postprandial state. Brit. med. J. 1971I, 380–381.
Wright, N., Prescott, L.F.: Paracetamol overdosage: potentiation of hepatotoxicity by previous drug therapy. Scot. med. J. 18, 56–58 (1973).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Prescott, L.F. (1975). Pathological and Physiological Factors Affecting Drug Absorption, Distribution, Elimination, and Response in Man. In: Gillette, J.R., Mitchell, J.R. (eds) Concepts in Biochemical Pharmacology. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 28 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46314-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-46314-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46316-7
Online ISBN: 978-3-642-46314-3
eBook Packages: Springer Book Archive